FOŘTOVÁ, Andrea, Václav HÖNIG, Martin PALUS, Jiří SALÁT, Martina PÝCHOVÁ, Lenka KRBKOVÁ, Tereza VYHLÍDALOVÁ, Michal F. KŘÍHA, Aleš CHRDLE and Daniel RŮŽEK. Serum and cerebrospinal fluid phosphorylated neurofilament heavy subunit as a marker of neuroaxonal damage in tick-borne encephalitis. Journal of General Virology. Microbiology Society, 2022, vol. 103, No 5, p. 1-7. ISSN 0022-1317. Available from: https://dx.doi.org/10.1099/jgv.0.001743.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Serum and cerebrospinal fluid phosphorylated neurofilament heavy subunit as a marker of neuroaxonal damage in tick-borne encephalitis.
Authors FOŘTOVÁ, Andrea (203 Czech Republic), Václav HÖNIG (203 Czech Republic), Martin PALUS (203 Czech Republic), Jiří SALÁT (203 Czech Republic), Martina PÝCHOVÁ (203 Czech Republic, belonging to the institution), Lenka KRBKOVÁ (203 Czech Republic, belonging to the institution), Tereza VYHLÍDALOVÁ, Michal F. KŘÍHA, Aleš CHRDLE and Daniel RŮŽEK (203 Czech Republic, guarantor, belonging to the institution).
Edition Journal of General Virology, Microbiology Society, 2022, 0022-1317.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10607 Virology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.800
RIV identification code RIV/00216224:14310/22:00125775
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1099/jgv.0.001743
UT WoS 000798232700001
Keywords in English biomarker; brain injury; flavivirus; neurofilament; tick-borne encephalitis
Tags 14110214, 14110318, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 2/6/2022 10:36.
Abstract
Extensive axonal and neuronal loss is the main cause of severe manifestations and poor outcomes in tick-borne encephalitis (TBE). Phosphorylated neurofilament heavy subunit (pNF-H) is an essential component of axons, and its detection in cerebrospinal fluid (CSF) or serum can indicate the degree of neuroaxonal damage. We examined the use of pNF-H as a biomarker of neuroaxonal injury in TBE. In 89 patients with acute TBE, we measured CSF levels of pNF-H and 3 other markers of brain injury (glial fibrillary acidic protein, S100B and ubiquitin C-terminal hydrolase L1) and compared the results to those for patients with meningitis of other aetiology and controls. Serum pNF-H levels were measured in 80 patients and compared with findings for 90 healthy blood donors. TBE patients had significantly (P<0.001) higher CSF pNF-H levels than controls as early as hospital admission. Serum pNF-H concentrations were significantly higher in samples from TBE patients collected at hospital discharge (P<0.0001) than in controls. TBE patients with the highest peak values of serum pNF-H, exceeding 10 000 pg ml−1, had a very severe disease course, with coma or tetraplegia. Patients requiring intensive care had significantly higher serum pNF-H levels than other TBE patients (P<0.01). Elevated serum pNF-H values were also observed in patients with incomplete recovery (P<0.05). Peak serum pNF-H levels correlated positively with the duration of hospitalization (P=0.005). Measurement of pNF-H levels in TBE patients might be useful for assessing disease severity and determining prognosis.
PrintDisplayed: 6/6/2024 21:44